Skip to content
Use caution Drug recall · FDA · Published June 23, 2015

Recall: Cortisol-MC 10mg Capsules by Abrams Royal Pharmacy II

Abrams Royal Pharmacy II recalls Cortisol-MC 10mg capsules due to failed content uniformity. Check lot numbers and expiry dates for affected units.

🇺🇸 FDA recall #D-1231-2015DrugAbrams Royal Pharmacy II ›
Take action

Contact the company

Recalling firmAbrams Royal Pharmacy II, LLC4909 W Park Blvd Ste 177 · Plano, TX 75093-2311
✎ GovInfoNow plain-language explainer

What happened, in plain English

Abrams Royal Pharmacy II, LLC has recalled Cortisol-MC, a 10mg capsule, because the product failed content uniformity specifications. This means the amount of active ingredient in the pills may not be consistent. The recall affects specific lots distributed in the United States, including Texas. Read more at govinfonow.com/recall/44148-abrams-royal-pharmacy-ii-llc-recalls-cortisol-mc-10mg-cap.

Source Summary by GovInfoNow · govinfonow.com/recall/44148-abrams-royal-pharmacy-ii-llc-recalls-cortisol-mc-10mg-cap · Updated October 12, 2026 · FDA enforcement record: FDA #D-1231-2015

Cite this page

“Recall: Cortisol-MC 10mg Capsules by Abrams Royal Pharmacy II.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44148-abrams-royal-pharmacy-ii-llc-recalls-cortisol-mc-10mg-cap. Based on FDA recall #D-1231-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1231-2015%22&limit=1).

Why it’s dangerous

The product failed uniformity of dosage units specifications, which can result in some pills containing too much or too little of the active ingredient. This inconsistency may lead to ineffective treatment or potential side effects from incorrect dosing.

Who’s affected

Patients who were prescribed Cortisol-MC 10mg capsules from Abrams Royal Pharmacy II are affected. Individuals possessing the specific lot numbers and expiry dates listed below are at risk of receiving inconsistent dosing.

How to tell if you have this one

Check if you have Cortisol-MC, 10mg CAP, Rx Only, packaged in 30 or 90 count bottles. Look for NDC 88888-0043-31 and Lot # 04012015@45 with an expiry date of 09/28/2015.

  • Brand
    Abrams Royal Pharmacy II
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if your Cortisol-MC capsules match the recalled NDC, lot number, and expiry date.

  2. Contact your pharmacy

    Reach out to Abrams Royal Pharmacy II or your prescribing doctor for instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed in Texas.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “United States including: Texas” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Texas.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Jun 23, 201512. FDA classified it Class III: Jul 8, 201523. Published in FDA’s Enforcement Report: Jul 15, 201534. FDA terminated the recall: Jan 13, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC for the recalled product?

The National Drug Code (NDC) for the recalled product is 88888-0043-31.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1231-2015 (June 23, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1231-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA